Your browser doesn't support javascript.
loading
Increased length-dependent activation of human engineered heart tissue after chronic α1A-adrenergic agonist treatment: testing a novel heart failure therapy.
Rupert, C; López, J E; Cortez-Toledo, E; De la Cruz Cabrera, O; Chesler, N C; Simpson, P C; Campbell, S G; Baker, A J.
Afiliación
  • Rupert C; Propria LLC, Branford, Connecticut, United States.
  • López JE; Division of Cardiovascular Medicine, Department of Internal Medicine, University of California Davis, Davis, California, United States.
  • Cortez-Toledo E; Division of Cardiovascular Medicine, Department of Internal Medicine, University of California Davis, Davis, California, United States.
  • De la Cruz Cabrera O; Kent State University, Kent, Ohio, United States.
  • Chesler NC; Edwards Lifesciences Foundation Cardiovascular Innovation Research Center, Irvine, California, United States.
  • Simpson PC; Department of Biomedical Engineering, University of California, Irvine, California, United States.
  • Campbell SG; Cardiology Division, Veterans Affairs Medical Center, San Francisco, California, United States.
  • Baker AJ; Department of Medicine, University of California, San Francisco, California, United States.
Am J Physiol Heart Circ Physiol ; 324(3): H293-H304, 2023 03 01.
Article en En | MEDLINE | ID: mdl-36637971

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Madre Pluripotentes Inducidas / Insuficiencia Cardíaca Límite: Animals / Humans Idioma: En Revista: Am J Physiol Heart Circ Physiol Asunto de la revista: CARDIOLOGIA / FISIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Madre Pluripotentes Inducidas / Insuficiencia Cardíaca Límite: Animals / Humans Idioma: En Revista: Am J Physiol Heart Circ Physiol Asunto de la revista: CARDIOLOGIA / FISIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos